Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Product Development of Intensity Modulation for Bolus Electron Conformal Therapy

    SBC: Decimal, LLC            Topic: 102

    Project Summary Abstract ObjectiveThis project aims to elevate electron beam therapyEBTtechnologywhich provides effective radiation treatment for superficial cancersdepthandltcmto that of other external beam radiotherapiesXRTe gx rays and protonsby bringing electron intensity modulation into the clinicChallengeApproximatelyof radiotherapy patientsin USA annuallyreceive EBT for a portion of their t ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  2. SBIR Phase I: High-Salinity Produced Water Management by Recovering Solid Waste with Low Grade Thermal Energy

    SBC: SAVENGY TECHNOLOGIES., LLC            Topic: ET

    The broader impact/commercial potential of this SBIR Phase I project is to develop a desalination system powered by solar energy. Water is used for lithium and rare metal mining, requiring energy-efficient water treatment to produce fresh water and concentrated brines. This type of water treatment in mineral recovery systems can yield valuable critical materials as byproducts. Many lithium and rar ...

    SBIR Phase I 2019 National Science Foundation
  3. Selective Kv7.2/3 activators for the treatment of neuropathic pain

    SBC: Knopp Biosciences            Topic: 106

    Project Summary The successful management of chronic pain is inadequate in many patients and has contributed to the abuse of and addiction to opioidsa continuing major public health crisis in the United States and worldwideThe development of non addictive pain therapeutics can help counter opioid addiction and benefit patientsincluding those who suffer from neuropathic painand in particular diabet ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. A single dose long-acting non-addictive polymer conjugate formulation of buprenorphine that provides immediate and prolonged analgesia for post-operative pain

    SBC: SERINA THERAPEUTICS INC            Topic: NINDS

    PAProject Summary Abstract SERis a long acting polymer pro drug of buprenorphine that is being developed to treat postoperative pain following major surgeries such as bunionectomyabdominoplastythoracotomy and knee and hip surgerySERhas no biological activity by itselfbut when administered in vivo by subcutaneous injection it enters the vascular compartment where a plasma esterasebutyrylcholinester ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Minimally Invasive Intercostal Nerve Block Device to Treat Severe Pain and Reduce Usage of Opiates

    SBC: Thermaquil, Inc.            Topic: 106

    Project SummaryMost of thek Americans who undergo thoracotomy each year receive opiates to reduce postoperative pain because clinicians have few non addictivecost effective choices to control the severe pain patients often experience in the first two weeks after surgeryManaging pain post thoracotomy is critical to enable patients to take deep breaths and removevia coughinglung secretions that othe ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  6. SBIR Phase I: Enabling Computation on Encrypted Data on the Cloud and Beyond

    SBC: Usencryption Inc.            Topic: IT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to enhance data security by solving the current problem of securing data in use through encryption. It has the potential to build trust on the cloud by overcoming the technical challenges of building a fully homomorphic encryption solution. This will allow data owners to encrypt their confi ...

    SBIR Phase I 2019 National Science Foundation
  7. SBIR Phase II: Magnetic Quantum Dots for Cell Separation and Characterization

    SBC: Core Quantum Technologies            Topic: BM

    The broader/commercial impact of this SBIR phase II project will develop magnetic and fluorescent reagents for the separation and analysis of cells from tissue samples stored in biobanks, central repositories for biological samples, including tissues, cells, blood, sera, and urine, and their associated patient data, used in research to identify new methods to diagnose and treat disease; this indus ...

    SBIR Phase II 2019 National Science Foundation
  8. PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Gra

    SBC: Mosaix Software, Inc.            Topic: NCIPC

    Project Summary Abstract This is the phase II application of a NIDA funded SBIR grant titled Demand Reduction Smart Tool for Analysis and Research STAR NIDA Grant R DA A The goal of Phase II is to develop a commercial grade Self Service Visual Analysis SSVA tool based on Phase I STAR Prototype empowering decision makers and managers in drug demand reduction field to make data driven decisions in m ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Decontamination of Category A Viruses on Porous Surfaces and Sensitive Equipment

    SBC: MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORP.            Topic: 18NCERP2

    In the Phase II project, METSS will continue the development of a safe, robust, rapid, and effective chlorine dioxide (ClO2) gas dispersion system to be used for on-site room decontamination in hospital and non-hospital settings. The heart of the decontamination system is a proprietary ClO2 generating micro-reactor technology that is used to quickly and safely generate ClO2 on-site. This technolog ...

    SBIR Phase II 2019 Environmental Protection Agency
  10. Plasma-Enhancement of Absorbers for Improved Removal of PFOS and PFOA from Water

    SBC: AA Plasma LLC            Topic: 18NCERP2

    New regulations and advisory levels for perfluoroalkyl substances have resulted in increased drinking water treatment costs or abandonment of drinking water sources. Treatment technologies are needed that can achieve low parts-per-trillion levels. Presently, there are insufficient treatment technologies that can destructively remove perfluorooctanoic acid (PFOA) and/or perfluorooctane sulfonic aci ...

    SBIR Phase II 2019 Environmental Protection Agency
US Flag An Official Website of the United States Government